Japan may see LNG demand up if renewables are slow; Canada there to deliver, officials say
Japan's demand for liquefied natural gas (LNG) may grow by more than 10% to some 74 million metric tons by 2040 under a ...
Are thinner people harming the environment? Novo emissions rise on Wegovy demand
Novo Nordisk (NVO) said on Wednesday that its emissions rose by nearly a quarter in 2024 and will continue to increase up to 2030 as production increases to meet demand for its obesity blockbuster ...
TotalEnergies posts drop in Q4 profit on weak oil demand
French oil major TotalEnergies reported a 15% drop in fourth quarter earnings on Wednesday, closing out a year marked by low ...
Trump adds Middle East tensions to macro picture as trade war keeps volatility high
EU mid-market update: Trump adds Middle East tensions to macro picture as trade war keeps volatility high; Novo Nordisk rises ...
Before the Bell: What every Canadian investor needs to know today
In Canada, investors are getting results from Suncor Energy Inc. and Great-West Lifeco Inc. On Wall Street, markets are ...
These Stocks Are Moving the Most Today: Alphabet, AMD, Apple, Palantir, Disney, Novo Nordisk, FMC, Uber, PDD, and More
Shares of Google parent Alphabet slump after quarterly revenue misses analysts’ expectations, AMD’s data-center revenue disappoints, and a report says China is considering a probe into Apple’s App ...
Customized living materials: Genetic tweaks enable precise control
Rice University researchers have revealed novel sequence-structure-property relationships for customizing engineered living ...
Investing17h
European stocks slip lower; earnings, services PMI data in focus
TotalEnergies (EPA: TTEF) raised its dividend Wednesday, as the French energy giant attempted to appease investors after a ...
Novo doubles down on next-gen weight loss therapy despite early setback
Novo Nordisk (NVO) stock in focus as company announces new Phase 3 trial for its next-gen weight loss drug CagriSema despite ...
Novo Nordisk defends next-gen obesity drug CagriSema, details new trial
Novo Nordisk defended its next-generation obesity drug candidate CagriSema on Wednesday following late-stage trial data ...
Microsoft8h
How real-world businesses are transforming with AI – with 50 new stories
The post contains 50 new customer stories, which appear at the beginning of each section of customer lists. The post will be ...
Form 8.3 - Loungers Plc
G3X76VBG9SB50405 February 2025Form 8.3 re. Loungers Plc PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the ...